EPS for ProMIS Neurosciences Inc. (PMN) Expected At $-0.01

March 20, 2018 - By Adrian Erickson

 EPS for ProMIS Neurosciences Inc. (PMN) Expected At $ 0.01

Analysts expect ProMIS Neurosciences Inc. (TSE:PMN) to report $-0.01 EPS on March, 21.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $-0.01 EPS. After having $-0.01 EPS previously, ProMIS Neurosciences Inc.’s analysts see 0.00 % EPS growth. The stock decreased 3.00% or $0.015 during the last trading session, reaching $0.485. About 293,236 shares traded. ProMIS Neurosciences Inc. (TSE:PMN) has 0.00% since March 20, 2017 and is . It has underperformed by 16.70% the S&P500.

ProMIS Neurosciences Inc., a development stage biotech company, discovers and develops precision medicine therapeutics for treatment of neurodegenerative diseases, primarily Alzheimer's disease and amyotrophic lateral sclerosis (ALS). The company has market cap of $106.73 million. The Company’s proprietary target discovery engine is based on the use of two complementary techniques. It currently has negative earnings. The firm applies its thermodynamic, computational discovery platform?ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.